How to kill Pseudomonas-emerging therapies for a challenging pathogen
| Autor: | Victoria E. Coles, Derek C K Chan, Lori L. Burrows, Luke N. Yaeger |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Phage therapy
medicine.drug_class medicine.medical_treatment Antibiotics Antimicrobial peptides Virulence Computational biology medicine.disease_cause General Biochemistry Genetics and Molecular Biology 03 medical and health sciences Antibiotic resistance History and Philosophy of Science Drug Resistance Bacterial medicine Phage Therapy Pathogen 030304 developmental biology 0303 health sciences biology 030306 microbiology Pseudomonas aeruginosa business.industry General Neuroscience Pseudomonas biology.organism_classification 3. Good health Anti-Bacterial Agents business |
| Zdroj: | Annals of the New York Academy of SciencesReferences. 1496(1) |
| ISSN: | 1749-6632 |
| Popis: | As the number of effective antibiotics dwindled, antibiotic resistance (AR) became a pressing concern. Some Pseudomonas aeruginosa isolates are resistant to all available antibiotics. In this review, we identify the mechanisms that P. aeruginosa uses to evade antibiotics, including intrinsic, acquired, and adaptive resistance. Our review summarizes many different approaches to overcome resistance. Antimicrobial peptides have potential as therapeutics with low levels of resistance evolution. Rationally designed bacteriophage therapy can circumvent and direct evolution of AR and virulence. Vaccines and monoclonal antibodies are highlighted as immune-based treatments targeting specific P. aeruginosa antigens. This review also identifies promising drug combinations, antivirulence therapies, and considerations for new antipseudomonal discovery. Finally, we provide an update on the clinical pipeline for antipseudomonal therapies and recommend future avenues for research. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text